KIRSTEN REVITTE: Open Payments
NPI 1124636568 · BOULDER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,127 in 52 payments from 18 companies in 2025. Trend: 2023 $1,077 · 2024 $1,698 · 2025 $1,127
Food & beverage: $929Education: $198
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $254 |
| ABBVIE INC. | 9 | $139 |
| Organon LLC | 10 | $113 |
| PFIZER INC. | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $79 |
| Amgen Inc. | 3 | $67 |
| GENZYME CORPORATION | 3 | $65 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $49 |
| Botanix SB Inc | 2 | $44 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, OTEZLA, VTAMA, RINVOQ, CIBINQO, COSENTYX.
Industry payments across CO — which companies pay providers there.
